Amphotericin B-Induced Hyperbilirubinemia

Am J Ther. 2019 Nov/Dec;26(6):e765-e766. doi: 10.1097/MJT.0000000000000939.

Authors

Divyansh Bajaj¹, Soumya Thumma¹, Ankit Agrawal², Joseph Mattana¹

Affiliations

¹ Saint Vincent Medical Center Frank H. Netter School of Medicine Quinnipiac University Bridgeport, CT.
² Saint Peter's University Hospital Rutgers Robert Wood Johnson School of Medicine New Brunswick, NJ.

PMID: 30730333
DOI: 10.1097/MJT.0000000000000939

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Amphotericin B / adverse effects*
Antibiotic Prophylaxis / adverse effects*
Antibiotic Prophylaxis / methods
Antifungal Agents / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Bilirubin / blood
Chemical and Drug Induced Liver Injury / blood
Chemical and Drug Induced Liver Injury / diagnosis
Chemical and Drug Induced Liver Injury / etiology*
Humans
Hyperbilirubinemia / blood
Hyperbilirubinemia / chemically induced*
Hyperbilirubinemia / diagnosis
Immunocompromised Host
Invasive Fungal Infections / immunology
Invasive Fungal Infections / prevention & control
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / immunology
Liver Function Tests
Male
Middle Aged

Substances

Antifungal Agents
Amphotericin B
Bilirubin